CRELUX GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CRELUX GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3400
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Crelux GmbH (Crelux), a subsidiary of WuXi AppTec (Shanghai) Co Ltd, is a drug discovery company that discovers drug solutions for pharmacy, biotech and research organizations. The company offers customized and integrated services in areas of drug discovery, X-ray crystallography, protein supply, biophysical analysis and fragment screening. It develops fragment screening platform, which include measurements of enzymatic activities, Kon and off binding kinetics, KD analyses and stability determination of proteins. Crelux’s X intract biophysical analytics and screening platform is made of a versatile series of orthogonal assay technologies for hit validation. The company offers services to support small and large molecules in biopharmaceutical products. Crelux is headquartered in Martinsried, Germany.

CRELUX GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CRELUX GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CRELUX GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
AiCuris Enters Into Drug Discovery Agreement With 4SC Discovery And Crelux 10
UCB Enters Into Drug Discovery Agreement With Crelux And 4SC Discovery 12
4SC Enters Into Co-Development Agreement With Crelux And Ribological 13
Acquisition 14
WuXi AppTec Acquires Crelux 14
CRELUX GmbH – Key Competitors 15
CRELUX GmbH – Key Employees 16
CRELUX GmbH – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
CRELUX GmbH, Pharmaceuticals & Healthcare, Key Facts 2
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CRELUX GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CRELUX GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AiCuris Enters Into Drug Discovery Agreement With 4SC Discovery And Crelux 10
UCB Enters Into Drug Discovery Agreement With Crelux And 4SC Discovery 12
4SC Enters Into Co-Development Agreement With Crelux And Ribological 13
WuXi AppTec Acquires Crelux 14
CRELUX GmbH, Key Competitors 15
CRELUX GmbH, Key Employees 16

List of Figures
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[CRELUX GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GEA Group Aktiengesellschaft:企業の戦略・SWOT・財務分析
    GEA Group Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary GEA Group Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • XCyton Diagnostics Ltd-医療機器分野:企業M&A・提携分析
    Summary XCyton Diagnostics Ltd (Xcyton) is a molecular biology company that develops and markets diagnostics products and services. The company provides ELISA kit for the detection of HIV infection; ELISA products for the detection of Neurocysticercosis, Hepatitis C and Japanese encephalitis. It pro …
  • Acxiom Corporation:企業の戦略・SWOT・財務分析
    Acxiom Corporation - Strategy, SWOT and Corporate Finance Report Summary Acxiom Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Kowa Co Ltd (7807):企業の財務・戦略的SWOT分析
    Kowa Co Ltd (7807) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • CropEnergies AG (CE2):企業の財務・戦略的SWOT分析
    CropEnergies AG (CE2) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • DCS Corporation:企業の戦略・SWOT・財務情報
    DCS Corporation - Strategy, SWOT and Corporate Finance Report Summary DCS Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Surgical Care Affiliates LLC:医療機器:M&Aディール及び事業提携情報
    Summary Surgical Care Affiliates LLC (SCA), a subsidiary of UnitedHealth Group Inc is a healthcare organization that offers patient care and healthcare services. The organization's services include scheduling optimization, physician governance and engagement, case costing, profitability analysis and …
  • MicuRx Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary MicuRx Pharmaceuticals Inc (MicuRx) is a developer of antibiotics for drug-resistant bacterial infections. The company develops a pipeline of antimicrobial agents using its proprietary drug discovery platform to treat both gram-positive and gram-negative bacterial infections. Its lead produc …
  • Toshiba Plant Systems & Services Corporation (1983):企業の財務・戦略的SWOT分析
    Toshiba Plant Systems & Services Corporation (1983) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s ke …
  • Zecotek Photonics Inc (ZMS):医療機器:M&Aディール及び事業提携情報
    Summary Zecotek Photonics Inc. (Zecotek) is a photonics technology company that focuses on developing advanced materials and integrated optoelectronic devices for optical precision surgery, high resolution medical imaging and biopharmaceutical research. It develops and sells scintillation crystals, …
  • Fukuda Denshi Co Ltd (6960):医療機器:M&Aディール及び事業提携情報
    Summary Fukuda Denshi Co Ltd (Fukuda Denshi) is a medical device company, which develops, manufactures, and commercializes medical equipment including cardiology, patient monitoring, vascular screening and ultrasound systems. The company’s product portfolio includes electrocardiographs, stress tests …
  • Northam Platinum Limited:企業の戦略・SWOT・財務情報
    Northam Platinum Limited - Strategy, SWOT and Corporate Finance Report Summary Northam Platinum Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Calavo Growers, Inc. (CVGW):企業の財務・戦略的SWOT分析
    Calavo Growers, Inc. (CVGW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Medtronic PLC:企業のM&A・事業提携・投資動向
    Medtronic PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Medtronic PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • MEDACTA International SA:製品パイプライン分析
    Summary MEDACTA International SA (MEDACTA) is a medical device company that offers orthopedic surgical equipment. The company conducts research, development, manufacturing and commercialization of orthopedic products, neurosurgical systems and instrumentation. It offers prosthetic solutions for hip, …
  • FLX Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary FLX Bio Inc (FLX Bio) focuses on the discovery, development and commercialization of novel immuno-oncology agents. The company’s pipeline product, FLX925 is a drug targeting the FLT3 mutations which is found in patients with acute myeloid leukemia (AML). FLX925 simultaneously targets a secon …
  • The Quaker Oats Company:企業の戦略・SWOT・財務分析
    The Quaker Oats Company - Strategy, SWOT and Corporate Finance Report Summary The Quaker Oats Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • MAMEE-Double Decker (M) Sdn Bhd:企業の戦略的SWOT分析
    MAMEE-Double Decker (M) Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Mitsubishi Chemical Holdings Corporation:企業の戦略・SWOT・財務情報
    Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Payton Planar Magnetics Ltd (PAY):企業の財務・戦略的SWOT分析
    Payton Planar Magnetics Ltd (PAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆